RETROVIR, HIVID, SAQUINAVIR AIDS REGIMEN
Executive Summary
RETROVIR, HIVID, SAQUINAVIR AIDS REGIMEN will be one of four three-component regimens to start into clinicals under the sponsorship of the Intercompany Collaboration on AIDS Drug Development. Hoffmann-La Roche International R&D President Juergen Drews, MD, announced the first regimens for the collaborative project at a meeting of the National Task Force on AIDS Drug Development, held April 14 in Arlington, Va.